Agentic AI-EnableD CardioVascular CAre TransfOrmation (ADVOCATE) Innovative Solutions Opening (ISO)

February 5, 2026

ADVOCATE ISO, ARPA-H-SOL-26-142, Amendment 01:

The purpose of ARPA-H-SOL-26-142, Amendment 01 is as follows:

1. Make a correction to Table 7 – Performer Collaboration Expectations under Section 1.2.5 Performer Collaboration Expectations (See highlighted text).
    
2. Revise the last paragraph under Section 5.1 Proposing Teams (See highlighted text) to read: “Proposers interested in submitting a proposal for TA3 cannot submit a proposal for TA1 and TA2 in any capacity (e.g. prime, subperformer, or multi-party team). TA3 proposers can only submit one proposal for the TA3 work outlined in this solicitation.” 
   .... Read More

The Advanced Research Projects Agency for Health (ARPA-H) Agentic AI-Enabled Cardiovascular Care Transformation (ADVOCATE) program will enable the development of an Agentic system that delivers autonomous and semi-autonomous clinical care directly to patients with cardiovascular disease (CVD).

Interested parties are invited to review the attached ADVOCATE Innovative Solutions Opening (ISO) ARPA-H -SOL-26-142.

For detailed information regarding the ADVOCATE Proposers' Day, review Special Notice (SN) ARPA-H-SN-26-139.